Latest News

01.21.21

Keeler Patners With Merakris Therapeutics, Developer of Biological Barrier Graft

Source: Keeler

01.21.21

Preliminary Results From Aldeyra’s Phase 3 Tranquility Trial Offer Promise for Patients With Dry Eye Syndrome, Says GlobalData

Source: GlobalData

01.21.21

New Global Survey Underscores Need for Myopia Education and Evidence-Based Approaches

Source: CooperVision

01.21.21

Ocular Therapeutix Presents Interim Topline Data from the Phase 1 Clinical Trial of OTX-TIC in Patients With Glaucoma

Source: Ocular Therapeutix

01.21.21

Surface Ophthalmics Announces Positive Topline Results From Phase 2 Trial for SURF-201 for the Treatment of Post-Cataract Surgery Pain and Inflammation

Source: Surface Ophthalmics

01.21.21

New Data Back Ability of Pfizer, BioNTech’s COVID-19 Vaccine to Foil UK Strain

Source: FirstWord

01.20.21

Alcon Launches Precision1 for Astigmatism Contact Lenses in the US

Source: Alcon

01.20.21

VSY Biotechnology Introduces Protectalon DUO Kit

Source: VSY Biotechnology

01.20.21

Ocuphire Announces Publication of ORION-1 Phase 2 Results for Nyxol in Clinical Ophthalmology

01.20.21

Oxurion NV Appoints Prof Alan Stitt as Chief Scientific Officer

Source: Oxurion

01.20.21

EyeCare Partners Acquires of Several Oklahoma-Based Independent Ophthalmology Practices

Source: Pegasus Equity Advisors

01.20.21

RightEye Launches New Version 4.0 to its Eye Tracking Technology

Source: RightEye

01.19.21

Market Scope: Refractive Surgery to Grow 9.6% a Year Through 2025, Despite COVID-19

Source: Market Scope

01.19.21

Rayner Enters Canadian Ophthalmology Market

Source: Rayner

01.19.21

More Adults with Vision Loss Seeking Help Staying Connected During Pandemic

Source: Hadley

01.19.21

CooperVision Announces 5 mm BOZD Customization for Paragon CRT and CRT Dual Axis Lenses

Source: CooperVision

View more stories